OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Meta‐analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non‐alcoholic steatohepatitis and non‐alcoholic steatohepatitis‐related fibrosis
Rutao Lin, Jianghua Zhou, Qinmei Sun, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 7, pp. 802-811
Closed Access | Times Cited: 8
Rutao Lin, Jianghua Zhou, Qinmei Sun, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 7, pp. 802-811
Closed Access | Times Cited: 8
Showing 8 citing articles:
Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysis
Rutao Lin, Qinmei Sun, Xin Xin, et al.
Metabolism (2024) Vol. 161, pp. 156043-156043
Closed Access | Times Cited: 6
Rutao Lin, Qinmei Sun, Xin Xin, et al.
Metabolism (2024) Vol. 161, pp. 156043-156043
Closed Access | Times Cited: 6
Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?
Tobias Puengel, Frank Tacke
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1249-1263
Open Access | Times Cited: 5
Tobias Puengel, Frank Tacke
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1249-1263
Open Access | Times Cited: 5
Panagiotis Theofilis, Evangelos Oikonomou, Paschalis Karakasis, et al.
Liver International (2025) Vol. 45, Iss. 3
Closed Access
Pegbelfermin for reducing transaminase levels in patients with non-alcoholic steatohepatitis: a dose-response meta-analysis of randomized controlled trials
Yangguang Lu, Bohuai Yu, Yiran Bu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Yangguang Lu, Bohuai Yu, Yiran Bu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction
Kento Takeuchi, Kanji Yamaguchi, Yusuke Takahashi, et al.
Research Square (Research Square) (2024)
Open Access
Kento Takeuchi, Kanji Yamaguchi, Yusuke Takahashi, et al.
Research Square (Research Square) (2024)
Open Access
Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction
Kento Takeuchi, Kanji Yamaguchi, Yusuke Takahashi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Kento Takeuchi, Kanji Yamaguchi, Yusuke Takahashi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Dawn of an era of effective treatments for MAFLD
Cameron Gofton, George Casella
Portal hypertension & cirrhosis (2024)
Open Access
Cameron Gofton, George Casella
Portal hypertension & cirrhosis (2024)
Open Access
Liver Steatosis: From Lipotoxicity to Cellular Damage
Tobias Puengel, Frank Tacke
(2024), pp. 25-48
Closed Access
Tobias Puengel, Frank Tacke
(2024), pp. 25-48
Closed Access
